Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities    
Net loss attributable to common stockholders $ (299,738) $ (271,868)
Adjustments to reconcile net loss to net cash used in operating activities:    
Use of restricted cash and cash equivalents for certain operating activities 82,927 55,842
Loss on early extinguishment of debt 114,335 80,510
Depreciation 32,773 30,286
Amortization of debt issuance costs and discount 5,639 4,943
Stock-based compensation 62,013 176,123
Non-cash LNG inventory write-downs 14,978 13,599
Total (gains) losses on derivatives, net 94,859 (77,760)
Net cash from settlement of derivative instruments (17,437) (175)
Net loss attributable to non-controlling interest (103,317) (16,664)
Other (1,826) (2,021)
Changes in operating assets and liabilities:    
Accounts and interest receivable 461 (23,250)
Accounts payable and accrued liabilities 22,856 25,173
LNG inventory (14,376) (12,310)
Deferred revenue (1,955) (1,955)
Prepaid expenses and other (3,533) (2,316)
Net cash used in operating activities (11,341) (21,843)
Cash flows from investing activities    
Property, plant and equipment, net (1,352,400) (1,272,701)
Use of restricted cash and cash equivalents for the acquisition of property, plant and equipment 1,303,011 1,580,268
Investment in Cheniere Partners 0 (11,122)
Other (5,894) (7,479)
Net cash provided by (used in) investing activities (55,283) 288,966
Cash flows from financing activities    
Proceeds from issuances of long-term debt 2,584,500 3,504,478
Proceeds from sale of common units by Cheniere Partners 0 364,795
Investment in restricted cash and cash equivalents (2,282,903) (3,520,638)
Debt issuance and deferred financing costs (85,367) (228,882)
Distributions to non-controlling interest (39,644) (30,872)
Repayments of long-term debt (177,000) (100,000)
Payments related to tax withholdings for stock-based compensation (9,218) (71,913)
Proceeds from exercise of stock options 6,265 0
Other (964) 11,119
Net cash used in financing activities (4,331) (71,913)
Net increase (decrease) in cash and cash equivalents (70,955) 195,210
Cash and cash equivalents—beginning of period 960,842 201,711
Cash and cash equivalents—end of period $ 889,887 $ 396,921